BerGenBio shares more than double on COVID-19 drug trial news

BerGenBio shares more than double on COVID-19 drug trial news
Reuters: Health
Shares of Norwegian pharmaceutical company BerGenBio rose nearly 160% on Wednesday after news that a drug it is developing has been selected for a British trial of potential COVID-19 treatments.


No comments:

Post a Comment